Junliang Ge
Shenyang Agricultural University(CN)Capital Medical University(CN)National Center for Spinal Disorders(HU)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Glioma Diagnosis and Treatment, PI3K/AKT/mTOR signaling in cancer, Plant-Microbe Interactions and Immunity, Cancer-related Molecular Pathways
Most-Cited Works
- → Novel Gold Nanorod-Based HR1 Peptide Inhibitor for Middle East Respiratory Syndrome Coronavirus(2019)95 cited
- → Synergistic Amplification of Oxidative Stress–Mediated Antitumor Activity via Liposomal Dichloroacetic Acid and MOF‐Fe2+(2019)58 cited
- → Selected by gene co-expression network and molecular docking analyses, ENMD-2076 is highly effective in glioblastoma-bearing rats(2019)52 cited
- → Identification of novel natural inhibitors targeting AKT Serine/Threonine Kinase 1 (AKT1) by computational study(2022)31 cited
- → Bioactive multi-engineered hydrogel offers simultaneous promise against antibiotic resistance and wound damage(2020)30 cited
- → An elegant nitroreductase responsive fluorescent probe for selective detection of pathogenic Listeria in vitro and in vivo(2019)25 cited